Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig

被引:61
作者
Nakamura, Y [1 ]
Ohya, Y [1 ]
Onaka, U [1 ]
Fujii, K [1 ]
Abe, I [1 ]
Fujishima, M [1 ]
机构
[1] Kyushu Univ, Fac Med, Dept Internal Med 2, Higashi Ku, Fukuoka 81282, Japan
关键词
insulin resistance; calcium channel; vascular smooth muscle; electrophysiology; troglitazone; pioglitazone; metformin; bezafibrate;
D O I
10.1038/sj.bjp.0701669
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The actions of troglitazone, pioglitazone, metformin and bezafibrate, agents that improve insulin-resistance, on voltage-dependent Ca2+ channels in arterial smooth muscle cells were examined by use of the conventional and nystatin-perforated whole-cell clamp methods. Single cells were freshly isolated from resistance mesenteric arteries of guinea-pigs. The actions of these agents on 77 mM K+-induced contraction of the isolated arteries were also examined with the use of isometric tension recording. 2 The thiazolidinedione derivatives, troglitazone and pioglitazone, inhibited whole-cell Ca2+ currents in a dose-dependent manner with dissociation constants of 3.0 mu M and 44.9 mu M and Hill coefficients of 0.61 and 0.68, respectively. These two agents inhibited the 77 mM K+-induced contraction with similar potencies as those inhibiting the Ca2+ currents. Metformin and bezafibrate had no apparent effects on the Ca2+ current or high K+-induced contraction. 3 The inhibitory action of troglitazone on Ca2+ currents was not affected by the command potential, the holding potential, or the stimulation frequency, suggesting that its mode of the action differs from that of known organic Ca2+ channel antagonists. 4 The inhibitory action of troglitazone on Ca2+ currents was not affected by the addition of insulin to, or the removal of glucose from, the solutions. 5 In conclusion, the thiazolidinedione derivatives directly inhibited the voltage-dependent Ca2+ channels in a different manner from that of organic Ca2+ channel antagonists. This inhibitory action on Ca2+ channels was not a common feature of insulin-sensitizing agents.
引用
收藏
页码:675 / 682
页数:8
相关论文
共 31 条
[1]   NITRENDIPINE BLOCK OF CARDIAC CALCIUM CHANNELS - HIGH-AFFINITY BINDING TO THE INACTIVATED STATE [J].
BEAN, BP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6388-6392
[2]   BLOOD-PRESSURE-LOWERING BY PIOGLITAZONE - EVIDENCE FOR A DIRECT VASCULAR EFFECT [J].
BUCHANAN, TA ;
MEEHAN, WP ;
JENG, YY ;
YANG, D ;
CHAN, TM ;
NADLER, JL ;
SCOTT, S ;
RUDE, RK ;
HSUEH, WA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :354-360
[3]   INVITRO STUDIES ON THE ACTION OF CS-045, A NEW ANTIDIABETIC AGENT [J].
CIARALDI, TP ;
GILMORE, A ;
OLEFSKY, JM ;
GOLDBERG, M ;
HEIDENREICH, KA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (10) :1056-1062
[4]   ESSENTIAL-HYPERTENSION - AN INSULIN-RESISTANT STATE [J].
FERRANNINI, E ;
HAFFNER, SM ;
STERN, MP .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 :S18-S25
[5]   EFFECT OF INSULIN ON THE DISTRIBUTION AND DISPOSITION OF GLUCOSE IN MAN [J].
FERRANNINI, E ;
SMITH, JD ;
COBELLI, C ;
TOFFOLO, G ;
PILO, A ;
DEFRONZO, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :357-364
[6]   MODULATION BY A SULFONYLUREA OF INSULIN-DEPENDENT GLYCOGENESIS, BUT NOT OF INSULIN BINDING, IN CULTURED RAT HEPATOCYTES - EVIDENCE FOR A POSTRECEPTOR MECHANISM OF ACTION [J].
FLEIG, WE ;
NOETHERFLEIG, G ;
FUSSGAENGER, R ;
DITSCHUNEIT, H .
DIABETES, 1984, 33 (03) :285-290
[7]   CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].
FUJIWARA, T ;
YOSHIOKA, S ;
YOSHIOKA, T ;
USHIYAMA, I ;
HORIKOSHI, H .
DIABETES, 1988, 37 (11) :1549-1558
[8]   METFORMIN FOR OBESE, INSULIN-TREATED DIABETIC-PATIENTS - IMPROVEMENT IN GLYCEMIC CONTROL AND REDUCTION OF METABOLIC RISK-FACTORS [J].
GIUGLIANO, D ;
QUATRARO, A ;
CONSOLI, G ;
MINEI, A ;
CERIELLO, A ;
DEROSA, N ;
DONOFRIO, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (02) :107-112
[9]  
HIRAGA K, 1997, JPN J CLIN EXP MED, V74, P1184
[10]  
HOFFMAN C, 1991, ENDOCRINOLOGY, V129, P1915